| |
Audit
|
Compensation and Management Development
|
Corporate Governance
|
Research, Innovation and Technology
|
John L. McGoldrick
|
|
|
|
|
 Special Adviser
International AIDS Vaccine Initiative
Director Since 2001; Chairman since December 1, 2007
Special Adviser, International AIDS Vaccine Initiative, or IAVI, since September 2009. Chairman, Governor's Higher Education Council since April 2011. Chairman, Association of State Colleges and Universities (NJ) from January 2009 until June 2011. Mr. McGoldrick served as Executive Vice President, External Strategy Development, IAVI, from May 2006 until September 2009. Previously, Mr. McGoldrick served as Executive Vice President of Bristol-Myers Squibb Company from October 2005 until his retirement in April 2006. He held the position of Executive Vice President and General Counsel of Bristol-Myers Squibb Company from January 2000 to October 2005. Prior to that, he held the position of Senior Vice President, General Counsel from January 1995 and President, Medical Devices Group from December 1998 to January 2000. Before joining Bristol-Myers Squibb Company, Mr. McGoldrick was a senior partner and executive committee member of the law firm of McCarter & English. He is a graduate of Harvard College and the Harvard Law School.
|
View Transactions
|
| Date |
Type |
Shares Traded |
Price Range |
| Aug 5, 2003 |
Disposition (Non Open Market) |
147 |
45.74 |
|
|
Christopher B. Begley
|
|
|
|
|
 Retired Executive Chairman and Chief Executive Officer
Hospira, Inc.
Elected 2012
Director Since 2012
Mr. Begley served as Executive Chairman of the Board of Hospira from May 2007 until January 2012. He also served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. Prior to that, Mr. Begley served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott's Hospital Products division. He serves as non-executive chairman of the board of Hillshire Brands Company and as a director of DeVry Inc. Mr. Begley previously served as a director of Sara Lee Corporation, the Advanced Medical Technology Association (AdvaMed) and the National Center for Healthcare Leadership (NCHL). He earned a bachelor's degree from Western Illinois University and a master's degree in business administration from Northern Illinois University.
|
|
Betsy J. Bernard
|
|
|
|
|
 Retired President
AT&T Corp.
Elected 2009
Director Since 2009
A retired AT&T Corporation executive, Ms. Bernard currently serves on the boards of two other publicly traded companies. She has established an excellent record over 30 years of leading large, consumer-facing organizations in competitive, highly regulated markets. Since retiring from AT&T in 2003, Ms. Bernard has focused on her work with a number of corporate boards and on civic activities. At AT&T, she served as President, AT&T Business, a $26 billion division with more than four million customers. She also served as Executive Vice President and Chief Executive Officer, AT&T Consumer, among other leadership positions.
In addition to her AT&T experience, Ms. Bernard also served in senior executive roles at Qwest Communications International, US West Corporation and Pacific Bell, where she served as President and Chief Executive Officer of Pacific Telesis. She is a frequent speaker on women's leadership issues and served on the board of the International Women's Forum. Ms. Bernard holds a B.A. from St. Lawrence University, an MBA from Farleigh Dickinson University and An M.S. in Management from Stanford University.
|
|
Gail K. Boudreaux
|
|
|
|
|
 Chief Executive Officer, UnitedHealthcare
Executive Vice President, UnitedHealth Group
Director Since 2012
Chief Executive Officer, UnitedHealthcare since January 2011 and Executive Vice President, UnitedHealth Group since May 2008. From 2005 to 2008, Ms. Boudreaux served as Executive Vice President, External Operations for Health Care Services Corporation (HCSC), and prior to that served as President of Blue Cross and Blue Shield of Illinois, a division of HCSC. Before joining HCSC, Ms. Boudreaux held various positions at Aetna, including Senior Vice President, Aetna Group Insurance. Ms. Boudreaux earned a master's degree in business administration at Columbia Business School and a bachelor’s degree in psychology at Dartmouth College. She serves as a director of Xcel Energy Inc.
|
|
David C. Dvorak
|
|
|
|
|
.jpg) President and Chief Executive Officer
Zimmer Holdings, Inc.
Director Since 2007
David Dvorak was appointed President and Chief Executive Officer and a member of the Board of Directors of Zimmer Holdings on May 1, 2007.
Mr. Dvorak joined Zimmer in December 2001 shortly following the spin-off from Bristol-Myers Squibb. Prior to joining Zimmer, he was Senior Vice President, General Counsel and Secretary for STERIS Corporation, an Ohio-based leader in medical products sterilization and contamination prevention products and services. He practiced law with two major Ohio firms with a focus on corporate law, securities and mergers and acquisitions. Mr. Dvorak received his B.S. in business administration (finance) from Miami University (OH) and his J.D., magna cum laude, from Case Western Reserve University School of Law, where he was awarded The Order of the Coif.
|
View Transactions
|
| Date |
Type |
Shares Traded |
Price Range |
| Jan 14, 2004 |
Acquisition (Non Open Market) |
7,500 |
n/a |
|
Larry C. Glasscock
|
|
|
|
|
 Chairman of the Board of Zimmer Holdings, Inc.
Retired Chairman, President and Chief Executive Officer
WellPoint, Inc.
Director Since 2001
Retired Chairman of the Board of Directors of WellPoint, Inc. Mr. Glasscock served as President and Chief Executive Officer of WellPoint, Inc. from November 2004 (following the merger between Anthem, Inc. and WellPoint Health Networks Inc.) until June 2007 and as Chairman of WellPoint, Inc. from November 2005 until March 2010. Prior to Anthem's merger with WellPoint Health Networks in November 2004, Mr. Glasscock had served as Anthem's President and Chief Executive Officer since 2001 and also as Anthem's Chairman since 2003. Mr. Glasscock joined Anthem Insurance in 1998. Under his leadership, WellPoint and its predecessor companies grew from approximately 5 million medical members and $6 billion in revenue to approximately 34 million medical members and more than $60 billion in revenue. Mr. Glasscock earned a bachelor's degree in business administration from Cleveland State University. He also completed the Commercial Bank Management Program at Columbia University. He is a director of Sprint Nextel Corporation, Simon Property Group, Inc. and Sysco Corporation.
|
|
Robert A. Hagemann
|
|
|
|
|
 Senior Vice President and Chief Financial Officer
Quest Diagnostics Incorporated
Elected 2008 Director Since 2008
Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated ("Quest") since November 2003. Prior to that, Mr. Hagemann served as Vice President and Chief Financial Officer of Quest from August 1998. Mr. Hagemann joined a predecessor company, Corning Life Sciences, Inc., a subsidiary of Quest's former parent, Corning Incorporated, in 1992, and held a variety of senior financial positions before being named Vice President and Corporate Controller of Quest in 1996. Prior to joining Corning, Mr. Hagemann was employed by Prime Hospitality, Inc. and Crompton & Knowles, Inc. in senior financial positions. He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young. Mr. Hagemann holds a B.S. in accounting from Rider University and an MBA in finance from Seton Hall University.
|
|
Arthur J. Higgins
|
|
|
|
|
 Consultant
Blackstone Healthcare Partners Director Since 2007
Consultant, Blackstone Healthcare Partners since June 2010. Prior to that, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from 2006 to 2010 and Chairman of the Bayer HealthCare Executive Committee from 2004 to 2010. Prior to joining Bayer Healthcare, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001. He is a director of Resverlogix Corp. and Ecolab Inc. He is a past member of the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA), a past member of the Council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and past President of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Mr. Higgins graduated from Strathclyde University, Scotland and holds a B.S. in Biochemistry.
|
Cecil B. Pickett Ph.D.
|
|
|
|
|
 Retired President, Research and Development
Biogen Idec Inc.
Elected 2008
Director Since 2008
A retired director and executive officer of Biogen Idec Inc., Dr. Pickett is an elected member of the Institute of Medicine of The National Academy of Sciences. Dr. Pickett served as President, Research and Development of Biogen Idec from September 2006 until his retirement in October 2009. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, most recently as a Corporate Senior Vice President of Schering Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co. Dr. Pickett received his B.Sc. in biology from California State University at Hayward and his Ph.D. in cell biology from University of California at Los Angeles.
|
Stock transaction information provided by EDGAR Online. Zimmer makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting any such information. This listing does not include non-monetary transactions, such as stock option grants or shares purchased through the employee stock purchase plan. For recent transactions including non-monetary transactions, see our Section 16 SEC filings page.
